A synthetic decursin analog with increased in vivo stability suppresses androgen receptor signaling in vitro and in vivo
- PMID: 21870073
- DOI: 10.1007/s10637-011-9738-x
A synthetic decursin analog with increased in vivo stability suppresses androgen receptor signaling in vitro and in vivo
Abstract
Targeting androgen receptor (AR) signaling with agents distinct from current antagonist drugs remains a rational approach to the prevention and treatment of prostate cancer (PCa). Our previous studies have shown that decursin and isomer decursinol angelate (DA), isolated from the Korean medicinal herb Angelica gigas Nakai, interrupt AR signaling and possess anti-PCa activities in vitro. In the LNCaP PCa cell model, these pyranoccoumarin compounds exhibit properties distinct from currently used antagonists (e.g., Casodex). However, both are rapidly de-esterified to decursinol, a partial AR agonist. We report here that a synthetic decursin analog, decursinol phenylthiocarbamate (DPTC), has greater in vivo stability than the parent compounds. DPTC-decursinol conversion was undetectable in mice. Furthermore, in LNCaP cells, DPTC decreased prostate specific antigen (PSA) expression, down-regulated AR abundance and mRNA and inhibited AR nuclear translocation. The effect of DPTC on AR and PSA mRNA and protein abundance was also observed in VCaP cells expressing wild type AR. DPTC inhibited growth of both PCa cell lines through G(1) cell cycle arrest and apoptosis, as did decursin and DA. Furthermore, i.p. administration of DPTC for 3 weeks suppressed the expression of AR target genes probasin and Nkx3.1 in mouse prostate glands. Overall, our data suggest that DPTC represents a prototype lead compound for development of in vivo stable and active novel decursin analogs for the prevention or therapy of PCa.
Similar articles
-
Chemistry, Pharmacology and Therapeutic Potential of Decursin: A Promising Natural Lead for New Drug Discovery and Development.Drug Des Devel Ther. 2024 Aug 23;18:3741-3763. doi: 10.2147/DDDT.S476279. eCollection 2024. Drug Des Devel Ther. 2024. PMID: 39286287 Free PMC article. Review.
-
Tanshinones from Chinese medicinal herb Danshen (Salvia miltiorrhiza Bunge) suppress prostate cancer growth and androgen receptor signaling.Pharm Res. 2012 Jun;29(6):1595-608. doi: 10.1007/s11095-012-0670-3. Epub 2012 Jan 27. Pharm Res. 2012. PMID: 22281759
-
A novel class of pyranocoumarin anti-androgen receptor signaling compounds.Mol Cancer Ther. 2007 Mar;6(3):907-17. doi: 10.1158/1535-7163.MCT-06-0231. Mol Cancer Ther. 2007. PMID: 17363485
-
Potent antiandrogen and androgen receptor activities of an Angelica gigas-containing herbal formulation: identification of decursin as a novel and active compound with implications for prevention and treatment of prostate cancer.Cancer Res. 2006 Jan 1;66(1):453-63. doi: 10.1158/0008-5472.CAN-05-1865. Cancer Res. 2006. PMID: 16397261
-
Oriental herbs as a source of novel anti-androgen and prostate cancer chemopreventive agents.Acta Pharmacol Sin. 2007 Sep;28(9):1365-72. doi: 10.1111/j.1745-7254.2007.00683.x. Acta Pharmacol Sin. 2007. PMID: 17723170 Review.
Cited by
-
Chemistry, Pharmacology and Therapeutic Potential of Decursin: A Promising Natural Lead for New Drug Discovery and Development.Drug Des Devel Ther. 2024 Aug 23;18:3741-3763. doi: 10.2147/DDDT.S476279. eCollection 2024. Drug Des Devel Ther. 2024. PMID: 39286287 Free PMC article. Review.
-
Anticancer potential of decursin, decursinol angelate, and decursinol from Angelica gigas Nakai: A comprehensive review and future therapeutic prospects.Food Sci Nutr. 2024 Jul 31;12(10):6970-6989. doi: 10.1002/fsn3.4376. eCollection 2024 Oct. Food Sci Nutr. 2024. PMID: 39479643 Free PMC article. Review.
-
CGK062, a small chemical molecule, inhibits cancer upregulated gene 2‑induced oncogenesis through NEK2 and β‑catenin.Int J Oncol. 2019 Apr;54(4):1295-1305. doi: 10.3892/ijo.2019.4724. Epub 2019 Feb 22. Int J Oncol. 2019. PMID: 30968157 Free PMC article.
-
Tanshinones from Chinese medicinal herb Danshen (Salvia miltiorrhiza Bunge) suppress prostate cancer growth and androgen receptor signaling.Pharm Res. 2012 Jun;29(6):1595-608. doi: 10.1007/s11095-012-0670-3. Epub 2012 Jan 27. Pharm Res. 2012. PMID: 22281759
-
A comprehensive review of the anticancer effects of decursin.Front Pharmacol. 2024 Feb 20;15:1303412. doi: 10.3389/fphar.2024.1303412. eCollection 2024. Front Pharmacol. 2024. PMID: 38444945 Free PMC article. Review.
References
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials
Miscellaneous